Principal Financial Group’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$166K Sell
80,284
-35,034
-30% -$72.5K ﹤0.01% 2146
2025
Q1
$254K Buy
115,318
+1,758
+2% +$3.87K ﹤0.01% 2020
2024
Q4
$174K Buy
113,560
+10,909
+11% +$16.7K ﹤0.01% 2118
2024
Q3
$204K Buy
102,651
+84,205
+456% +$168K ﹤0.01% 2099
2024
Q2
$64.6K Sell
18,446
-17,758
-49% -$62.2K ﹤0.01% 2260
2024
Q1
$100K Sell
36,204
-704
-2% -$1.95K ﹤0.01% 2277
2023
Q4
$62.7K Buy
36,908
+2,024
+6% +$3.44K ﹤0.01% 2315
2023
Q3
$35.9K Buy
34,884
+1,190
+4% +$1.23K ﹤0.01% 2369
2023
Q2
$39.1K Buy
33,694
+2,800
+9% +$3.25K ﹤0.01% 2376
2023
Q1
$46.7K Sell
30,894
-2,199
-7% -$3.32K ﹤0.01% 2380
2022
Q4
$82.7K Buy
33,093
+6,342
+24% +$15.9K ﹤0.01% 2326
2022
Q3
$113K Sell
26,751
-634
-2% -$2.68K ﹤0.01% 2313
2022
Q2
$76K Sell
27,385
-1,074
-4% -$2.98K ﹤0.01% 2426
2022
Q1
$163K Buy
28,459
+553
+2% +$3.17K ﹤0.01% 2370
2021
Q4
$254K Sell
27,906
-9,628
-26% -$87.6K ﹤0.01% 2291
2021
Q3
$401K Buy
37,534
+1,663
+5% +$17.8K ﹤0.01% 2232
2021
Q2
$556K Sell
35,871
-3,008
-8% -$46.6K ﹤0.01% 2191
2021
Q1
$630K Sell
38,879
-2,074
-5% -$33.6K ﹤0.01% 2094
2020
Q4
$867K Buy
40,953
+8,441
+26% +$179K ﹤0.01% 1972
2020
Q3
$482K Sell
32,512
-1,186
-4% -$17.6K ﹤0.01% 2029
2020
Q2
$496K Buy
33,698
+10,814
+47% +$159K ﹤0.01% 1972
2020
Q1
$269K Buy
22,884
+1,572
+7% +$18.5K ﹤0.01% 1988
2019
Q4
$501K Buy
21,312
+10,069
+90% +$237K ﹤0.01% 1948
2019
Q3
$208K Buy
+11,243
New +$208K ﹤0.01% 2136
2019
Q2
Sell
-9,310
Closed -$228K 2248
2019
Q1
$228K Buy
9,310
+142
+2% +$3.48K ﹤0.01% 2098
2018
Q4
$238K Sell
9,168
-3,041
-25% -$78.9K ﹤0.01% 2089
2018
Q3
$386K Sell
12,209
-2,693
-18% -$85.1K ﹤0.01% 2017
2018
Q2
$579K Buy
+14,902
New +$579K ﹤0.01% 1942